Validation of LC–MS/MS bioanalytical methods for protein therapeutics

References

• 1 Li F, Fast D, Michael S. Absolute quantitation of protein therapeutics in biological matrices by enzymatic digestion and LC–MS. Bioanalysis 3(21), 2459–2480 (2011).Link, CAS, Google Scholar
• 2 Ewles M, Goodwin L. Bioanalytical approaches to analyzing peptides and proteins by LC–MS/MS. Bioanalysis 3(12), 1379–1397 (2011).Link, CAS, Google Scholar
• 3 Ezan E, Bitsch F. Critical comparison of MS and immunoassays for the bioanalysis of therapeutic antibodies. Bioanalysis 1(8), 1375–1388 (2009).Link, CAS, Google Scholar
• 4 van den Broek I, Niessen WM, van Dongen WD. Bioanalytical LC–MS/MS of protein-based biopharmaceuticals. J. Chromatogr. B 929, 161–179 (2013).Crossref, Medline, Google Scholar
• 5 Wang SJ, Wu ST, Gokemeijer J et al. Attribution of the discrepancy between ELISA and LC–MS/MS assay results of a PEGylated scaffold protein in post-dose monkey plasma samples due to the presence of anti-drug antibodies. Anal. Bioanal. Chem. 402(3), 1229–1239 (2012).Crossref, Medline, CAS, Google Scholar
• 6 Szapacs ME, Urbanski JJ, Kehler JR et al. Absolute quantification of a therapeutic domain antibody using ultra-performance liquid chromatography–mass spectrometry and immunoassay. Bioanalysis 2(1), 1597–1608 (2010).Link, CAS, Google Scholar
• 7 Whiteaker JR, Zhao L, Abbatiello SE et al. Evaluation of large scale quantitative proteomic assay development using peptide affinity-based mass spectrometry. Mol. Cell. Proteomics 10, M110.005645 (2011).Crossref, Medline, Google Scholar
• 8 European Medicines Agency, Committee for Medicinal Products for Human Use (CHMP). Guideline on Bioanalytical Method Validation. European Medicines Agency, London, UK (2011).Google Scholar
• 9 Bioanalytical Method Validation. Draft Guidance. US FDA, Rockville, MD, USA (2013).Google Scholar
• 10 Knutsson M, Schmidt R, Timmerman P. LC–MS/MS of large molecules in a regulated bioanalytical environment – which acceptance criteria to apply? Bioanalysis 5(18), 2211–2214 (2013).Link, CAS, Google Scholar
• 11 Guidance for Industry: Bioanalytical Method Validation. US FDA, Rockville, MD, USA (2001).Google Scholar
• 12 Viswanathan CT, Bansal S, Booth B et al. Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays. Pharm. Res. 24(10), 1962–1973 (2007).Crossref, Medline, CAS, Google Scholar